[1] NISMAN B.The stickland reaction[J].Bacteriological Reviews,1954,18(1):16-42. [2] FRIEDEN C.L-Glutamate dehydrogenase[J].The Enzymes,1963,7:3-24. [3] PAHLICH E,JOY K W.Glutamate dehydrogenase from pea roots: purification and properties of the enzyme[J]. Canadian Journal of Biochemistry,1971,49(1):127-138. [4] SMITH E L,AUSTEN B M,BLUMENTHAL K M,et al.Glutamate dehydrogenases[J].The Enzymes,1975,11:293-367. [5] 卢皙,刘上峰,赵守亮.GLUD1基因对人牙髓干细胞的体外增殖、分化和矿化的影响[J].上海口腔医学,2017,26(4):358-362. [6] HENSLEY C T,WASTI A T,DEBERARDINIS R J.Glutamine and cancer: cell biology, physiology, and clinical opportunities[J].Journal of Clinical Investigation,2013,123(9):3678-3684. [7] 王镜岩,朱圣庚,徐长法.生物化学:下册[M].北京:高等教育出版社,2002. [8] SPANAKI C,ZAGANAS I,KOUNOUPA Z,et al.The complex regulation of human glud1 and glud2 glutamate dehydrogenases and its implications in nerve tissue biology[J].Neurochemistry International,2012,61(4):470-481. [9] BOTMAN D,TIGCHELAAR W,VAN NOORDEN C J. Determination of glutamate dehydrogenase activity and its kinetics in mouse tissues using metabolic mapping (quantitative enzyme histochemistry)[J].Journal of Histochemistry and Cytochemistry,2014,62(11):802-812. [10] HANAHAN D,WEINBERG R A.Hallmarks of cancer: the next generation[J].Cell,2011,144(5):646-674. [11] MCGUIRK S,GRAVEL S P,DEBLOIS G,et al.PGC-1α supports glutamine metabolism in breast cancer[J]. Cancer and Metabolism,2013,1:22. [12] TIMMERMAN L A,HOLTON T,YUNEVA M,et al.Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target[J].Cancer Cell,2013,24(4):450-465. [13] YANG L F,MOSS T,MANGALA L S,et al.Metabolic shifts toward glutamine regulate tumor growth,invasion and bioenergetics in ovarian cancer[J].Molecular Systems Biology,2014,10(5):728. [14] PALLADINO A A,STANLEY C A.The hyperinsulinism/hyperammonemia syndrome[J]. Reviews in Endocrine and Metabolic Disorders,2010,11(3):171-178. [15] LIN M T,BEAL M F.Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases[J]. Nature,2006,443:787-795. [16] BERGER K,BRETELER M M,HELMER C,et al.Prognosis with Parkinson′s disease in Europe: a collaborative study of population-based cohorts. Neurologic diseases in the elderly research group[J]. Neurology,2000,54(S5):24-27. [17] 徐晓光,朱静,师俊玲,等.谷氨酸脱氢酶的基本特性及其与疾病的相关研究进展[J].生命科学,2016,28(11):1314-1320. [18] 曹燕,王柏山,牛广华,等.谷氨酸脱氢酶检测在慢性肝炎中的应用[J].上海医学检验杂志,2003,18(4):247-248. [19] 张立江,王佳楠,高俊芬.速率法检测血清GLDH 120例临床分析[J].中国社区医师,2008(11):90. [20] ZHANG J,WANG G,QIN M,et al.Glutamate dehydrogenase(GDH) regulates bioenergetics and redox homeostasis in human glioma[J] .Oncotarget, 2016, 295:799-800. [21] LIU G J,ZHU J,YU M L, et al.Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patients[J]. Journal of Translational Medicine, 2015,13:144. [22] CHEN R H, NISHIMURA M C,KHARBANDA S,et al.Hominoidspecific enzyme GLUD2 promotes growth of IDH1R132H glioma[J]. Proceedings of the National Academy of Sciences of the United States of America, 2014,111(39): 14217-14222. [23] PLAITAKIS A,LATSOUDIS H, KANAVOURAS K, et al.Gain -offunction variant in GLUD2 glutamate dehydrogenase modifies Parkinson's disease onset[J]. European Journal of Human Genetics,2010, 18(3): 336-341. |